Skip to main content

Main menu

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2021
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2021
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
News

Federal budget disappoints on universal pharmacare

Lauren Vogel
CMAJ April 08, 2019 191 (14) E406-E407; DOI: https://doi.org/10.1503/cmaj.109-5736
Lauren Vogel
CMAJ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Responses
  • Metrics
  • PDF
Loading

The 2019 federal budget lays the groundwork for universal pharmacare but stops short of commitments to a specific national plan. The budget also earmarks funds to address the opioid crisis, dementia and suicide prevention, among other health investments.

As a first step toward a national pharmacare program, the Trudeau government announced $35 million over four years, starting in 2019, to create a national drug agency. The new agency will assess the effectiveness of prescription drugs, negotiate prices on behalf of Canada’s drug plans, and develop a national formulary. To improve access to high-cost drugs for rare diseases, the government will also invest up to $1 billion over two years, starting in 2020, and $500 million a year thereafter.

These investments mark a “paradigm shift in the right direction,” says Steve Morgan, a professor in the faculty of medicine at the University of British Columbia. “The risk is that they are small steps and it’s relatively slow progress at the end of this mandate of the government.”

Canadians pay some of the highest drug prices in the world, with brand-name medicines costing an average 20% more in Canada than in peer countries. Canada’s patchwork of public and private drugs plans is part of the problem, says Morgan. “The most effective way to negotiate is through a national agency that buys on behalf of all purchasers in the system.”

Figure1

The Trudeau government announced support for a national drug agency and formulary, but not a national pharmacare program.

Image courtesy of daoleduc/iStock

According to Dr. Danielle Martin, vice-president of Women’s College Hospital, a national drug agency and formulary are “core and crucial” to support a national pharmacare plan. On their own, however, “these are necessary but not sufficient steps.”

“In the absence of a true pharmacare commitment in the budget, we’re now heading for a pharmacare election,” Martin says.

At a press conference, Finance Minister Bill Morneau said a pharmacare program can’t be created overnight and Canadians will have to “stay tuned” for more details.

It’s now looking like the government will hold off on announcing a plan until it receives the final recommendations of the Advisory Council on the Implementation of National Pharmacare in June. With a fall election on the horizon, “it would appear they’re setting this up as essentially platform material,” says Morgan.

It’s a high stakes gamble. “Certainly, the election has a possibility to wreak havoc with this kind of policy,” Morgan says. “If the Conservatives are elected into the federal government, the hopes of an evidence-based national pharmacare program are lost, because they’ve consistently opposed that kind of plan for the 22 years I’ve studied this file.”

Other key health investments in the budget include:

  • $134.4 million over five years to improve food security;

  • $30.5 million over five years for harm reduction and treatment programs to reduce opioid deaths;

  • $50 million to the Public Health Agency of Canada to support a national dementia strategy;

  • $36.5 million over five years to Health Canada to develop a pan-Canadian data and performance system for organ donation and transplantation;

  • Expanded tax relief for people experiencing infertility, using assisted reproduction methods, accessing multidisciplinary heath care services, or purchasing certain foot care devices;

  • $25 million over five years to support a pan-Canadian, bilingual suicide prevention service;

  • $2.4 million over three years for research into reducing barriers to blood plasma donation;

  • $12 million over three years to support employment for people with autism; and

  • $13.7 million over five years to improve the accessibility of government workplaces.

Footnotes

  • Posted on cmajnews.com on Mar. 20, 2019.

PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 191 (14)
CMAJ
Vol. 191, Issue 14
8 Apr 2019
  • Table of Contents
  • Index by author

Article tools

Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Federal budget disappoints on universal pharmacare
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Federal budget disappoints on universal pharmacare
Lauren Vogel
CMAJ Apr 2019, 191 (14) E406-E407; DOI: 10.1503/cmaj.109-5736

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Federal budget disappoints on universal pharmacare
Lauren Vogel
CMAJ Apr 2019, 191 (14) E406-E407; DOI: 10.1503/cmaj.109-5736
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Footnotes
  • Figures & Tables
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Canada’s long road to a vaccine injury compensation program
  • Health advocates want help handling online harassment
  • Reconciliation in health care must go beyond cultural sensitivity
Show more News

Similar Articles

Collections

  • Topics
    • Health policy
    • Canadian government

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions

Copyright 2021, Joule Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of the resources on this site in an accessible format, please contact us at cmajgroup@cmaj.ca.

Powered by HighWire